These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7817593)

  • 21. [Advances in ischaemic heart disease].
    Alegria E; Velasco A; Azcárate P
    Rev Med Univ Navarra; 2005; 49(3):16-30. PubMed ID: 16400973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A chronotherapeutic approach to the management of high-risk patients with hypertension/ischemic heart disease: introduction.
    Black HR
    Am J Hypertens; 1999 Feb; 12(2 Pt 2):33S-34S. PubMed ID: 10090292
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological modulation of mitochondrial function during ischemia and reperfusion.
    Monteiro P; Oliveira PJ; Conçalves L; Providência LA
    Rev Port Cardiol; 2003 Mar; 22(3):407-29. PubMed ID: 12847881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of the new cardioprotective agent thiotriazoline in the therapy of ischemic heart disease in older patients].
    Dunaev VV; Kraĭdashenko OV; Berezin AE
    Eksp Klin Farmakol; 1996; 59(1):21-3. PubMed ID: 8704625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
    Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM
    Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effectiveness and tolerability of bisoprolol vs. nifedipine in uremic patients with ischemic cardiopathy in dialysis treatment].
    Cice G; Di Benedetto A; Tagliamonte E; Ferrara L; Sorice P; Iacono A
    Cardiologia; 1997 Apr; 42(4):397-403. PubMed ID: 9244644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of hypertension in Italian nephrology out-patient clinics: the THIN Study.
    Russo D; Andreucci M; De Blasio A; Frattolillo P; Andreucci VE
    Semin Nephrol; 2005 Nov; 25(6):431-4. PubMed ID: 16298268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pumpan in the treatment of ischemic heart disease associated with arterial hypertension].
    Golikov AP; Babaian IS
    Ter Arkh; 2001; 73(10):68-9. PubMed ID: 11763522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dilzem-retard efficiency in patients with ischemic heart disease and heart failure].
    Gadzhiev AN
    Klin Med (Mosk); 2002; 80(6):45-8. PubMed ID: 12138803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The values of detection of free radical mediated reactions in patients.
    Czopf L; Nemes J; Varga J; Lantos J; Röth E
    Acta Chir Hung; 1997; 36(1-4):65-6. PubMed ID: 9408290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of captopril in therapeutic combinations].
    Alföldi S
    Acta Pharm Hung; 1997 Jul; 67(4):149-53. PubMed ID: 9289943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cracovian program for secondary prevention of ischemic heart disease. Methods of intervention].
    Kawecka-Jaszcz K; Pajak A; Jankowski P
    Przegl Lek; 2003; 60(3):133-5. PubMed ID: 14575012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial metabolism: pharmacological manipulation in myocardial ischaemia.
    Mitra B; Panja M
    J Assoc Physicians India; 2005 Jun; 53():552-60. PubMed ID: 16121812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of the antioxidant coenzyme Q10 as a cytoprotection variant in ischemic heart disease].
    Syrkin AL; Kogan AKh; Drinitsina SV; Kuznetsov AB; Pechorina EA; Frenkel' EE; Kuleshova NN; Golovnia LD
    Klin Med (Mosk); 1998; 76(7):24-8. PubMed ID: 9742773
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cardiovascular diseases, medical apocalypse of the 21st century?].
    Mielnik M; Steciwko A
    Przegl Lek; 2004; 61(3):159-64. PubMed ID: 15518325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescription of cardiovascular drugs in outpatient care: a survey of outpatients in a German university hospital.
    Harder S; Thürmann P; Thierolf C; Klepzig H
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):195-201. PubMed ID: 9587045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A national evaluation of specialists' clinics in primary care settings.
    Bowling A; Bond M
    Br J Gen Pract; 2001 Apr; 51(465):264-9. PubMed ID: 11458477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Views on the use of calcium channel blockers in the treatment of heart ischemia and hypertension].
    Halawa B
    Pol Merkur Lekarski; 1998 Sep; 5(27):107-10. PubMed ID: 10101470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The current aspects of the pharmacological protection of the ischemic myocardium].
    Chichkanov GG
    Eksp Klin Farmakol; 1994; 57(6):15-20. PubMed ID: 7756948
    [No Abstract]   [Full Text] [Related]  

  • 40. [The therapeutic prospects of ischemic cardiopathy].
    Rossi F; Matera MG; Filippelli A; Giasi M; Fici F
    Clin Ter; 1994 Apr; 144(4):333-53. PubMed ID: 8205757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.